# AUTONOMIX MEDICAL, INC. (AMIX) · Edgar & Edgarette company card

> Autonomix Medical (AMIX) reported revenue of $0 million in FY2026, operating margin null against a 1.2% median for surgical & medical instruments & apparatus, equity 77.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1617867 · fiscal year ended 2026-03-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/AMIX) · [JSON](https://www.pops4.com/boards/company/AMIX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -Infinity%) |
| Net margin | -Infinity% |
| Operating cash flow | −$12M |
| Capital spending | $10,000 |
| Free cash flow | −$12M |
| Cash | $7M |
| Long-term debt | — |
| Total assets | $8M |
| Total equity | $6M |
| Equity ÷ assets | 77.6% |
| Return on equity | -283.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -35.14 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative (-$12.3M in FY2026); operating loss: a margin of -Infinity% in FY2026

## Edgarette's reading

Exposure: revenue $0K (FY2026). Experience: one year on record; operating margin null, up from null. Soundness: equity 77.6% of assets, return on equity -283.5%. Credibility: four or more audited years, reasonable weight. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin null against a 1.2% median.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-01-16 ([filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926001381/0001437749-26-001381-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926034696/0001437749-26-034696-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926034696/0001437749-26-034696-index.htm)
- 8-K · filed 2026-09-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm)
- DEF 14A · filed 2026-09-14 · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926030345/0001437749-26-030345-index.htm)
- 8-K · filed 2026-08-26 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926029024/0001437749-26-029024-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926027429/0001437749-26-027429-index.htm)
- 8-K · filed 2026-07-28 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1617867/000143774926024597/0001437749-26-024597-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001617867.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1617867

## Cite

POPS4, Edgar & Edgarette: AUTONOMIX MEDICAL, INC. (AMIX) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/AMIX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.